Western Sydney Local Health District
wslhd.health.nsw.gov.auLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
35
Active
17
Phase 3
0
Total enrollment
16,674
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| NAC | — | — | — | — | — | 1 | |
| Anti-arrhythmic Drugs | — | — | — | — | — | 1 | |
| Medical therapy: Anti-arrhythmic drugs | — | — | — | — | — | 1 |
Next readouts
- 2026-06-30
- 2026-11-01
- 2027-09-01
Top conditions
- Kidney Transplant Rejection3
- Polyps3
- Colon Adenoma3
- Endoscopic Mucosal Resection3
- Adenoma Colon2
- Transplant Complication2
- Kidney Injury2
- Colon Polyp2
Frequently asked questions about Western Sydney Local Health District
- How many clinical trials does Western Sydney Local Health District have on ClinicalTrials.gov?
- Western Sydney Local Health District is listed as the lead sponsor on 35 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Western Sydney Local Health District's trials are in Phase 3?
- 0 of Western Sydney Local Health District's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Western Sydney Local Health District focus on?
- Western Sydney Local Health District's most-studied conditions on ClinicalTrials.gov are Kidney Transplant Rejection, Polyps, Colon Adenoma, Endoscopic Mucosal Resection, Adenoma Colon.
- When are Western Sydney Local Health District's next clinical trial readouts?
- Western Sydney Local Health District has 3 upcoming primary-completion readouts tracked here; the soonest is “Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia”, expected around 2026-06-30.